Chemoprevention with Food Phytochemicals: Screening, Rodent Studies, and Action Mechanisms

Journal of Medicinal Food

Volumn 1, Issue 1, 1998, Pages 29-38

  Murakami, Akira ^a   Koshimizu, Koichi ^a   Ohigashi, Hajime ^b  

^a KINKI UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0009508822     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.1998.1.29     Document Type: Article

References (68)

1. Arai, S. (1997). Studies on functional foods in Japan: State of the art. In Food Factors for Cancer Prevention. H. Ohigashi, T. Osawa, J. Terao, S. Watanabe, and T. Yoshikawa, eds. (Springer-Verlag, Berlin) pp. 47–51.
2. Ariza, M. E., Oberyszyn, A. S., Robertson, F. M., and Williams, M. V. (1996). Mutagenic potential of peripheral blood leukocytes: In vivo exposure to the carcinogen 7,12-dimethylbenz[a]anthracene, and the tumor promoter 12-O-tetradecanoylphorbol acetate followed by in vitro co-culture with AS52 cells. Cancer Lett 106, 9–16.
3. Bertram, J. S., Kolonel, X. N., and Meyskens, F. L. (1987). Rationale and strategies for chemoprevention in humans. Cancer Res 47, 3012–3031.
4. Blot, W. J., Li, J.Y., Taylor, P. R., Guo, W., Dawsey, S., Wang, G.Q., Yang, C. S., Zheng, S. R., Gail, M., Li, G. Y., Yu, Y., Liu, B. Q., Tangrea, J., Sun, Y. H., Liu, R., Fraumeni, F. Jr., Zhang, Y. H., and Li, B. (1993). Nutrition intervention trials in Linxian, China: Supplementation with specific vitamins/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85,1483–1491.
5. Broder, S. (1993). Perspectives on cancer in Japan and the United States. Jpn J Cancer Res 84, 821–830.
6. Buring, J. E. and Hennekens, C. H. (1995). Beta-carotene and cancer chemoprevention. J Cell Biochem 22, Suppl 226–230.
7. Carrol, K. K. (1991). Nutrition and cancer. In Fat, Nutrition, Toxicity, and Cancer. I. R. Rowland, ed. (CRC Press, Boca Raton, FL) pp. 439–453.
8. Crellin, J. K. and Philpot, J. (1989). Herbal Medicine Past and Present. I: A Reference Guide to Medicinal Plants. (Duke University Press, Durham, NC).
9. Farnsworth, N. and Bunyapraphatsara, N. (1992). Thai Medicinal Plants. (Prachachon Co., Ltd., Bangkok, Thailand).
10. Farr, D. R. (1997). Functional foods. Cancer Lett 114,59–63.
11. Fujiki, H., Suganuma, M., Komori, A., Yatusnami, J., Okabe, S., Ohta, T., and Sueoka, E. (1994). A new tumor promotion pathway and its inhibitors. Cancer Detect Prev 18,1–7.
12. Giacosa, A., Filiberti, R., Hill, M. J., and Faivre, J. (1997). Vitamins and cancer prevention. Eur J Cancer Prev 6(suppl), S47-S54.
13. Ito, Y., Yanase, S., Fujita, J., Harayama, T., Takashima, M., and Inayama, Y. (1981). A short-term in vitro assay for promoter substances using human lymphoblastoid cells latently infected with Epstein-Barr virus. Cancer Lett 13, 29–37.
14. Jacquat, C. and Bertossa, G. (1990). Plants from the Markets of Thailand. (Editions Duang Kamol, Bangkok, Thailand).
15. Johns, T. (1990). With Bitter Herbs They Shall Eat It. (The University of Arizona Press, Tucson).
16. Kensler, T. W., Egner, P. A., Taffe, B. G., and Trush, M. A. (1989). Role of free radicals in tumor promotion and progression. In Skin Carcinogenesis: Mechanisms and Human Relevance. T. J. Slaga, A. J. P. Klein-Szanto, R. K. Boutwell, D. E. Stevenson, H. L. Spitzer and B. D'Motto, eds. (Alan R. Liss, Inc., NY) pp. 233–248.
17. Klein, G. and Klein, E. (1985). Evolution of tumours and the impact of molecular oncology. Nature 315, 190–195.
18. Kokoglu, E., Belce, A., Ozyurt, E., and Tepeler, Z. (1990). Xanthine oxidase levels in human brain tumors. Cancer Lett 59,179–181.
19. Kondo, A., Ohigashi, H., Murakami, A., Suratwadee, J., and Koshimizu, K. (1993). 1'-Acetoxychavicol acetate as a potent inhibitor of tumor promoter-induced Epstein-Barr virus activation from Languas galanga, a traditional Thai condiment. Biosci Biotech Biochem 57, 1344–1345.
20. Koshimizu, K., Ohigashi, H., Tokuda, H., Kondo, A., and Yamaguchi, K. (1988). Screening of edible plants against anti-tumor promoting activity. Cancer Lett 39, 247–257.
21. Koshimizu, K. and Ohigashi, H. (1991). Search for naturally occurring anti-tumor promoters by inhibition of tumor promoter-induced Epstein-Barr virus activation. In Advances in New Drug Development. B. K. Kim, E. B. Lee, and Y. N. Han, eds. (Harl Rim Won Printing Co., Ltd., Seoul, South Korea) pp. 438–447.
22. Li, Y. and Trush, M. A. (1995). Oxidative stress and its relationship to carcinogen activation. In Oxidative Stress and Aging. R. G. Cutler, L. Packer, and A. Mori, eds. (Birkhauser Verlag, Basel, Switzerland) pp. 203–220.
23. Lippman, S. M., Benner, S. E., and Hong, W. K. (1994). Cancer chemoprevention. J Clin Oncol 12, 851–873.
24. Lorenzo, L., Vindigni, C., Megha, T., Funto, L., Pacenti, L., Musaro, M., Renieri, A., Seri, M., Anagnostopoulos, J., and Tosi, P. (1993). Epstein-Barr virus and gastric cancer: Data and unanswered questions. Int J Cancer 53, 898–901.
25. Market, M., Andrews, P. C., and Babior, B. M. (1984). Measurement of O2- production of human neutrophils: The preparation and assay of NADPH oxidase-containing particles from human neutrophils. Methods Enzymol 105, 358–365.
26. Murakami, A., Kondo, A., Nakamura, Y., Ohigashi, H., and Koshimizu, K. (1993). Possible anti-tumor promoting properties from edible plants of Thailand, and identification of an active constituent, cardamonin, of Boesenbergia pandurata. Biosci Biotech Biochem 57, 1971–1973.
27. Murakami, A., Ohigashi, H., and Koshimizu, K. (1994). Possible anti-tumor promoting properties of traditional Thai food items and some of their active constituents. Asia Pac J Clin Nutr 3,185–191.
28. Murakami, A., Jiwajinda, S., Koshimizu, K., and Ohigashi, H. (1995). Screening for in vitro anti-tumor promoting activities of edible plants from Thailand. Cancer Lett 95, 139–146.
29. Murakami, A., Nakamura, Y., Koshimizu, K., and Ohigashi, H. (1995). Glyceroglycolipids from Citrus hystrix, a traditional herb in Thailand, potently inhibits the tumor promoting activity of 12-O-tetradecanoylphor-bol-13-acetate in mouse skin. J Agrie Food Chem 43, 2779–2783.
30. Murakami, A., Ohigashi, H., and Koshimizu, K. (1996). Anti-tumor promotion with food phytochemicals: A strategy for cancer chemoprevention. Biosci Biotech Biochem 60,1–8.
31. Murakami, A., Ohura, S., Nakamura, Y., Koshimizu, K., and Ohigashi, H. (1996). 1'-Acetoxychavicol acetate, a superoxide anion generation inhibitor, potently inhibits tumor promotion by 12-O-tetradecanolyphorbol-13-acetate in ICR mouse skin. Oncology 53, 386–391.
32. Murakami, A., Morita, H., Safitri, R., Ramlan, A., Koshimizu, K., and Ohigashi, H. (1997). Screening for in vitro anti-tumor-promoting activities of edible plants from Indonesia. Cancer Detect Prev (in press).
33. Murakami, A., Kuki, W., Takahashi, Y., Yonei, H., Nakamura, Y., Ohto, Y., Ohigashi, H., and Koshimizu, K. (1997). Auraptene, a citrus coumarin, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in ICR mouse skin possibly through suppression of superoxide generation in leukocytes. Jpn J Cancer Res 88, 443–452.
34. Murakami, A., Kitazono, Y., Jiwajinda, S., Koshimizu, K., and Ohigashi, H. (1997). Niaziminin, a thiocarbamate from the leaves of Moringa oleifera, holds a strict structural requirement for inhibition of tumor-promoter-induced Epstein-Barr virus activation. Planta Med (in press).
35. Nakamura, Y., Murakami, A., Koshimizu, K., and Ohigashi, H. (1996). Identification of pheophorbide a and its related compounds as possible anti-tumor promoters in the leaves of Neptunia oleracea. Biosci Biotech Biochem 60,1028–1030.
36. Nakamura, Y., Murakami, A., Koshimizu, K., and Ohigashi, H. (1996). Inhibitory effect of pheophorbide a, a chlorophyll-related compound, on skin tumor promotion in ICR mouse. Cancer Lett 108, 247–255.
37. Natsukari, N., Kulaga, H., Baker, I., Wyatt, R. J., and Masserano, J. M. (1997). Increased cyclic AMP response to forskolin in Epstein-Barr virus-transformed human B lymphocytes derived from schizophrenics. Psychopharmacology (Berl) 130, 235–241.
38. Nishikura, K., Erikson, J., ar-Rushdi, A., Huebner, K., and Croce, C. M. (1985). The translocated c-myc oncogene of Raji Burkitt lymphoma cells is not expressed in human lymphoblastoid cell. Proc Natl Acad Sci USA 82, 2900–2904.
39. Noro, T., Sekiya, T., Katoh, M., Oda, Y., Miyase, T., Kurayanagi, M., Ueno, A., and Fukushima, S. (1988). Inhibitors of xanthine oxidase from Alpinia galanga. Chem Pharm Bull (Tokyo) 36, 244–248.
40. Ohigashi, H., Takamura, H., Koshimizu, K., Tokuda, H., and Ito, Y. (1986). Search for possible antitumor promoters by inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation: Ursolic acid and oleanolic acid from an anti-inflammatory. Chinese medicinal plant, Glechoma hederaceae L. Cancer Lett 30,143–151.
41. Ohigashi, H., Sakai, Y., Yamaguchi, K., Umezaki, I., and Koshimizu, K. (1992). Possible anti-tumor promoting properties of marine algae and in vivo activity of Wakame seaweed extract. Biosci Biotech Biochem 56, 994–995.
42. Ohigashi, H., Murakami, A., and Koshimizu, K. (1994). Antitumor promoters from edible plants. In Food Phytochemicals for Cancer Prevention. II: Teas, Spices, and Herbs. C.-T. Ho, T. Osawa, M.-T. Huang, and R. T. Rosen, eds. (American Chemical Society, Washington, DC) pp. 251–261.
43. Ohigashi, H., Murakami, A., and Koshimizu, K. (1996). An approach to functional food: Cancer preventive potential of vegetables and fruits and their active constituents. Nutr Rev 54, S24-S28.
44. Ohigashi, H., Murakami, A., Nakamura, Y., and Koshimizu, K. (1997). Anti-tumor promoters from edible Thai plants: Isolation, cancer preventive potential, and action mechanisms. In Food Factors for Cancer Prevention. H. Ohigashi, T. Osawa, J. Terao, S. Watanabe, and T. Yoshikawa, eds. (Springer-Verlag, Tokyo), pp. 188–193.
45. Ohnishi, M., Tanaka, T., Makita, H., Kawamori, T., Mori, H., Satoh, K., Hara, A., Murakami, A., Ohigashi, H., and Koshimizu, K. (1996). Chemopreventive effect of a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate, on rat oral carcinogenesis. Jpn J Cancer Res 87, 349–356.
46. Omenn, G. S., Goodman, G., Thornquist, M., Grizzle, J., Rosenstock, L., Barnhart, S., Balmes, J., Cherniack, M. G., Cullen, M. R., Glass, A., Keogh, J., Meyskens, F., Valanis, B., and Williams, J. (1994). The Beta-Carotene and Retinol Efficacy Trial (CARET) for chemoprevention of lung cancer in high risk populations—smokers and asbestos-exposed workers. Cancer Res 54 (Suppl), S2038-S2043.
47. Panousis, C. G., and Rowe, D. T. (1997). Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase. J Virol 71, 4752–4760.
48. Pitot, H. C., and Dragan, Y. P. (1991). Facts and theories concerning the mechanisms of carcinogenesis. FASEB J 5, 2280–2286.
49. Ponglux, D., Wongseripipatana, S., Phadungcharoen, T., Runangrungsri, N., and Likhitwitayawuid, K. (1987). Medicinal Plants. (Victory Power Point Co., Ltd., Bangkok, Thailand).
50. Prochaska, H. J., and Talalay, P. (1991). The role of NAD(P)-H: Quinone reductase in protection against the toxicity of quinones and related agents. In Oxidative Stress: Oxidants and Antioxidants. H. Sies, ed. (Academic Press, London) pp. 195–211.
51. Reiners, J. J., Jr., Pence, B. C., Barcus, M. C. S., and Cantu, A. R. (1987). 12-O-tetradecanoylphorbol-13-acetate-dependent induction of xanthine dehydrogenase and conversion to xanthine oxidase in murine epidermis. Cancer Res 47,1775–1779.
52. Siemonsma, J. S., and Piluek, K. (1994). Plant Resources of South-East Asia. 8: Vegetables. Prosea Education, Bogor, Indonesia).
53. Steele, V. E., Pereira, M. A., Sigman, C. C., and Kelloff, G. J. (1995). Cancer chemoprevention agent development strategies for genistein. J Nutr 123 (Suppl.), S713-S716.
54. Talalay, P. (1992). Chemical protection against cancer by induction of electrophile detoxification (phase II) enzymes. In Cellular and Molecular Targets for Chemoprevention. V. E. Steele, G. D. Stoner, C. W. Boon, and GJ. Kelloff, eds. (CRC Press, Boca Raton, FL) pp. 193–205.
55. Tanaka, T., Makita, H., Kawamori, T., Kawabata, K., Mori, H., Murakami, A., Satoh, K., Hara, A., Ohigashi, H., and Koshimizu, K. (1997). A xanthine oxidase inhibition 1'-acetoxychavicol acetate inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 18,1113–1118.
56. Tanaka, T., Kawabata, K., Kakumoto, M., Makita, H., Matsunaga, K., Mori, H., Satoh, K., Hara, A., Murakami, A., Koshimizu, K., and Ohigashi, H. (1997). Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate. Jpn J Cancer Res 88, 821–830.
57. Tanaka, T., Kawabata, K., Kakumoto, M., Matsunaga, K., Mori, H., Murakami, A., Kuki, W., Takahashi, Y., Yonei, H., Satoh, K., Hara, A., Maeda, M., Ota, T., Odashima, S., Koshimizu, K., and Ohigashi, H. (1997). Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by citrus auraptene in rats. Carcinogenesis (in press).
58. Tanaka, T., Makita, H., Mori, H., Murakami, A., Kuki, W., Takahashi, Y., Yonei, H., Satoh, K., Hara, A., Ohigashi, H., and Koshimizu, K. (1997). Citrus auraptene inhibits chemically-induced colonic aberrant crypt foci in rats. Carcinogenesis 18, 2155–2161.
59. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. (1994). The alpha-tocopherol, beta-carotene lung cancer prevention study: Design, methods, participant characteristics, and compliance. N Engl J Med 330,1029–1035.
60. Tokuda, H., Ohigashi, H., Koshimizu, K., and Ito, Y. (1986). Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Lett 33, 279–285.
61. Vatanasapt, V., Martin, N., Sriplung, H., Chindavijak, K., Sontipong, S., Srimporn, S., Parkin, D. M., and Ferly, J. (1993). Cancer in Thailand (IARC Technical Report No. 16, Lyon).
62. Watanabe, S., Kimira, M., and Sobue T. (1997). Diet and cancer: Epidemiological approaches. In Food Factors for Cancer Prevention. H. Ohigashi, T. Osawa, J. Terao, S. Watanabe, and T. Yoshikawa, eds. Springer-Verlag, Tokyo, Japan) pp. 3–8.
63. Wattenberg, L. W. (1985). Chemoprevention of cancer. Cancer Res 45,1–8.
64. Wei, H. and Frenkel, K. (1991). In vivo formation of oxidized DNA bases in tumor promoter-treated mouse skin. Cancer Res 51, 4443–4449.
65. Weitzman, S. A., and Stossel, T. P. (1981). Mutation caused by human phagocytes. Science 212, 546–547.
66. Weitzman, S. A., and Stossel, T. P. (1984). Phagocyte-induced mutation in Chinese hamster ovary cells. Cancer Lett 22, 337–341.
67. Weitzman, S. A., Weitberg, A. B., Clark, E. P., and Stossel, T. P. (1985). Phagocytes as carcinogens: Malignant transformation produced by human neutrophils. Science 227, 1231–1233.
68. Young, L. S. and Sixbey, J. W. (1988). Epstein-Barr virus and epithelial cells: A possible role for the virus in the development of cervical carcinoma. Cancer Surv 7, 507–518.